Literature DB >> 27841146

PD1 and PD-L1 in ependymoma might not be therapeutic targets.

Benoit Dumont, Fabien Forest, Pierre Dal Col, Georgia Karpathiou, Jean-Louis Stephan, François Vassal, Michel Péoc'h.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27841146     DOI： 10.5414/NP300988

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN： 0722-5091            Impact factor:   1.368


× No keyword cloud information.
  2 in total

1.  Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.

Authors:  Davis A Witt; Andrew M Donson; Vladimir Amani; Daniel C Moreira; Bridget Sanford; Lindsey M Hoffman; Michael H Handler; Jean M Mulcahy Levy; Kenneth L Jones; Anandani Nellan; Nicholas K Foreman; Andrea M Griesinger
Journal:  Pediatr Blood Cancer       Date:  2018-01-19       Impact factor: 3.167

2.  Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma.

Authors:  Song Xue; Man Hu; Peifeng Li; Ji Ma; Li Xie; Feifei Teng; Yufang Zhu; Bingjie Fan; Dianbin Mu; Jinming Yu
Journal:  Oncotarget       Date:  2017-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.